A Phase Ib, Multi-Center, Randomized, Vehicle- and Comparator-Controlled Trial, Double-Blind for the Investigational Medicinal Products, Observer-Blind for the Comparators to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test
Latest Information Update: 15 Apr 2020
At a glance
- Drugs BOS 475 (Primary) ; Betamethasone; Calcipotriol
- Indications Plaque psoriasis
- Focus Adverse reactions
- Sponsors Boston Pharmaceuticals
Most Recent Events
- 10 Apr 2020 Status changed from active, no longer recruiting to completed.
- 12 Feb 2020 Status changed from not yet recruiting to active, no longer recruiting.
- 09 Jan 2020 New trial record